Open AccessTrastuzumab emtansine in HER2-positive metastatic breast cancer: what is the best sequence?
Author(s) -
Francesco Ricci,
Christophe Le Tourneau
Publication year - 2018
Publication title -
chinese clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.733
H-Index - 22
eISSN - 2304-3873
pISSN - 2304-3865
DOI - 10.21037/cco.2017.10.08
Subject(s) - trastuzumab , trastuzumab emtansine , medicine , metastatic breast cancer , breast cancer , human epidermal growth factor receptor 2 , oncology , monoclonal antibody , pertuzumab , cancer , lapatinib , cancer research , antibody , immunology